United States Healthcare Equipment & Supplies

Medtronic PLC (MDT)

Track

Track

Medtronic PLC experienced three insider trading transactions over the past ninety days, totaling 654,751.19 USD in sales. These divestments occurred following a positive earnings report. The stock price has appreciated 17.9% during this period, currently trading at 67.81% of its fifty-two-week range.
Ticker: MDT Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Medtronic PLC. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
373.60
Quantity 80,376 +0.4%
Value US$1,309,878
3.3
KIIL HARRY SKIP Officer Officer
Transaction date
Proposed sale
Price
63.91
Quantity 36,983
Value US$2,836,423
Walter Matthew R. SVP, Chief HR Officer Officer
Transaction date
Sale
Price
408.37
Quantity 82,114 -34.5%
Value US$2,734,773
Walter Matthew R. Officer Officer
Transaction date
Proposed sale
Price
83.15
Quantity 3,102
Value US$257,931
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
80.45
Quantity 228 -0.6%
Value US$18,343
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
80.44
Quantity 3,961 -9.6%
Value US$318,623
3.3
KIIL HARRY SKIP Officer Officer
Transaction date
Proposed sale
Price
80.44
Quantity 4,189
Value US$336,965
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
97.82
Quantity 385 -1.2%
Value US$37,661
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
97.83
Quantity 668 -2.0%
Value US$65,347
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
97.77
Quantity 19,255 -36.3%
Value US$1,882,561
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
97.66
Quantity 30,568 -36.5%
Value US$2,985,375
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
97.86
Quantity 1,648 -1.9%
Value US$161,273
3.3
KIIL HARRY SKIP Officer Officer
Transaction date
Proposed sale
Price
97.71
Quantity 52,524
Value US$5,132,217
3.4
Smith Gregory L EVP Global Ops & Supply Chain Officer
Transaction date
Sale
Price
102.08
Quantity 500 -1.1%
Value US$51,040
3.4
Smith Gregory L EVP Global Ops & Supply Chain Officer
Transaction date
Sale
Price
102.06
Quantity 325 -0.7%
Value US$33,170
3.4
Smith Gregory L EVP Global Ops & Supply Chain Officer
Transaction date
Sale
Price
102.05
Quantity 227 -0.5%
Value US$23,165
3.4
Smith Gregory L EVP Global Ops & Supply Chain Officer
Transaction date
Sale
Price
102.04
Quantity 825 -1.7%
Value US$84,183
3.4
Smith Gregory L EVP Global Ops & Supply Chain Officer
Transaction date
Sale
Price
102.03
Quantity 1,995 -4.0%
Value US$203,550
3.4
Smith Gregory L EVP Global Ops & Supply Chain Officer
Transaction date
Sale
Price
101.99
Quantity 1,942 -3.7%
Value US$198,065
3.4
Smith Gregory L EVP Global Ops & Supply Chain Officer
Transaction date
Sale
Price
101.93
Quantity 24,186 -31.8%
Value US$2,465,279
3.4
Smith Gregory L Officer Officer
Transaction date
Proposed sale
Price
101.95
Quantity 30,000
Value US$3,058,452
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
91.59
Quantity 200 -0.6%
Value US$18,318
3.3
KIIL HARRY SKIP EVP & President Cardiovascular Officer
Transaction date
Sale
Price
91.58
Quantity 8,405 -19.0%
Value US$769,730
3.3
KIIL HARRY SKIP Officer Officer
Transaction date
Proposed sale
Price
91.58
Quantity 8,605
Value US$788,049
2.4
Jellison William R Non-Executive Director
Transaction date
Purchase
Price
92.37
Quantity 2,500 +100.0%
Value US$230,925
2.4
Jellison William R Non-Executive Director
Transaction date
Purchase
Price
92.73
Quantity 2,500 +inf%
Value US$231,825
3.2
Salmon Sean Officer Officer
Transaction date
Proposed sale
Price
86.81
Quantity 18,378
Value US$1,595,469
2.0
Wall Brett A. EVP & Pres Neuroscience Officer
Transaction date
Sale
Price
90.00
Quantity 12,437 -23.3%
Value US$1,119,330
2.0
Wall Brett A. Officer Officer
Transaction date
Proposed sale
Price
90.00
Quantity 12,437
Value US$1,119,330
2.0
Wall Brett A. EVP & Pres Neuroscience Officer
Transaction date
Sale
Price
80.41
Quantity 3,000 -6.9%
Value US$241,230
2.0
Wall Brett A. EVP & Pres Neuroscience Officer
Transaction date
Sale
Price
80.41
Quantity 6,850 -13.5%
Value US$550,808
2.0
Wall Brett A. Officer Officer
Transaction date
Proposed sale
Price
80.41
Quantity 9,850
Value US$792,038
2.9
PARKHILL KAREN L Former Director Non-Executive Director
Transaction date
Proposed sale
Price
89.73
Quantity 30,000
Value US$2,691,794
2.9
PARKHILL KAREN L Former Director Non-Executive Director
Transaction date
Proposed sale
Price
90.58
Quantity 15,000
Value US$1,358,740
2.9
PARKHILL KAREN L Former BOD
Transaction date
Proposed sale
Price
91.16
Quantity 15,000
Value US$1,367,348
2.9
PARKHILL KAREN L Former Director Non-Executive Director
Transaction date
Proposed sale
Price
92.49
Quantity 22,712
Value US$2,100,633
2.9
PARKHILL KAREN L Former Director Non-Executive Director
Transaction date
Proposed sale
Price
91.76
Quantity 23,848
Value US$2,188,205
2.9
PARKHILL KAREN L Former BOD
Transaction date
Proposed sale
Price
91.74
Quantity 48,825
Value US$4,479,310
2.9
PARKHILL KAREN L Former BOD
Transaction date
Proposed sale
Price
89.87
Quantity 55,179
Value US$4,958,718
2.9
PARKHILL KAREN L Former Officer Officer
Transaction date
Proposed sale
Price
90.00
Quantity 2,668
Value US$240,120
1.9
Martha Geoffrey Chairman and CEO Executive Director
Transaction date
Sale
Price
83.82
Quantity 1,594 -1.1%
Value US$133,609
1.9
Martha Geoffrey Chairman and CEO Executive Director
Transaction date
Sale
Price
83.76
Quantity 17,519 -10.8%
Value US$1,467,391
1.9
Martha Geoffrey Officer; Director Executive Director
Transaction date
Proposed sale
Price
83.77
Quantity 19,113
Value US$1,601,102
2.7
Marinaro Michael EVP & President, Surgical OU Officer
Transaction date
Sale
Price
83.14
Quantity 854 -3.0%
Value US$71,002
3.2
Salmon Sean EVP & President Cardiovascular Officer
Transaction date
Sale
Price
85.12
Quantity 16,035 -24.9%
Value US$1,364,899
3.2
Salmon Sean EVP & President Cardiovascular Officer
Transaction date
Sale
Price
85.15
Quantity 13,066 -16.9%
Value US$1,112,570
3.2
Salmon Sean EVP & President Cardiovascular Officer
Transaction date
Sale
Price
85.06
Quantity 1,594 -2.0%
Value US$135,586
3.2
Salmon Sean Officer Officer
Transaction date
Proposed sale
Price
85.13
Quantity 30,695
Value US$2,613,202
2.0
Wall Brett A. EVP & Pres Neuroscience Officer
Transaction date
Planned sale
Price
82.17
Quantity 4,997 -14.7%
Value US$410,603
2.0
Wall Brett A. Officer Officer
Transaction date
Proposed sale
Price
82.17
Quantity 4,997
Value US$410,603
3.4
Smith Gregory L EVP Global Ops & Supply Chain Officer
Transaction date
Sale
Price
83.84
Quantity 10,000 -17.6%
Value US$838,400
3.4
Smith Gregory L Officer Officer
Transaction date
Proposed sale
Price
83.84
Quantity 10,000
Value US$838,442
2.0
Wall Brett A. EVP & Pres Neuroscience Officer
Transaction date
Planned sale
Price
83.38
Quantity 1,000 -2.9%
Value US$83,380
2.0
Wall Brett A. Officer Officer
Transaction date
Proposed sale
Price
83.38
Quantity 1,000
Value US$83,380
2.7
Marinaro Michael EVP & President, Surgical OU Officer
Transaction date
Planned sale
Price
84.11
Quantity 1,352 -4.5%
Value US$113,717
2.7
Marinaro Michael Officer Officer
Transaction date
Proposed sale
Price
84.11
Quantity 1,352
Value US$113,717
2.0
Wall Brett A. EVP & Pres Neuroscience Officer
Transaction date
Planned sale
Price
87.97
Quantity 2,000 -7.7%
Value US$175,940
2.0
Wall Brett A. Officer Officer
Transaction date
Proposed sale
Price
87.97
Quantity 2,000
Value US$175,940
2.3
TEN HOEDT ROB EVP and Pres. Global Regions Officer
Transaction date
Sale
Price
86.58
Quantity 3,706 -7.8%
Value US$320,865
2.3
TEN HOEDT ROB EVP and Pres. Global Regions Officer
Transaction date
Sale
Price
86.59
Quantity 1,808 -4.0%
Value US$156,555
2.3
TEN HOEDT ROB Officer Officer
Transaction date
Proposed sale
Price
86.59
Quantity 5,514
Value US$477,440
3.2
Salmon Sean EVP & President Cardiovascular Officer
Transaction date
Sale
Price
80.50
Quantity 16,631 -31.5%
Value US$1,338,736
2.3
TEN HOEDT ROB EVP and Pres. Global Regions Officer
Transaction date
Sale
Price
81.54
Quantity 2,404 -5.2%
Value US$196,015
2.9
PARKHILL KAREN L EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
110.00
Quantity 682 -1.9%
Value US$75,020
2.5
Surface Carol A SVP, Chief HR Officer Officer
Transaction date
Sale
Price
105.30
Quantity 6,000 -17.4%
Value US$631,800
3.7
ANDERSON RICHARD H Non-Executive Director
Transaction date
Purchase
Price
103.26
Quantity 5,010 +4.8%
Value US$517,333
2.9
PARKHILL KAREN L EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
110.00
Quantity 682 -1.9%
Value US$75,020
1.2
Lerman Bradley E SVP General Counsel & Corp Sec Officer
Transaction date
Planned sale
Price
126.58
Quantity 49,147 -50.2%
Value US$6,221,027
3.2
Salmon Sean EVP & Pres Diabetes/Cardiovasc Officer
Transaction date
Sale
Price
134.09
Quantity 7,290 -17.9%
Value US$977,516
3.2
Salmon Sean EVP & Pres Diabetes/Cardiovasc Officer
Transaction date
Sale
Price
134.08
Quantity 21,129 -38.8%
Value US$2,832,976
1.2
Lerman Bradley E SVP General Counsel & Corp Sec Officer
Transaction date
Planned sale
Price
131.52
Quantity 4,000 -7.7%
Value US$526,080
2.9
PARKHILL KAREN L EVP & Chief Financial Officer Officer
Transaction date
Planned sale
Price
124.47
Quantity 605 -0.7%
Value US$75,304
2.0
Wall Brett A. EVP & Pres Neuroscience Officer
Transaction date
Planned sale
Price
128.07
Quantity 2,473 -10.3%
Value US$316,717
Liddicoat John R EVP & President of Americas Officer
Transaction date
Planned sale
Price
126.65
Quantity 34,656 -44.9%
Value US$4,389,182
1.9
Martha Geoffrey CEO Executive Director
Transaction date
Planned sale
Price
118.83
Quantity 9,308 -10.2%
Value US$1,106,070
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-16 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
80,376 +0.4%
373.60
US$1,309,878 		80,376 +0.4% 373.60 US$1,309,878
2026-09-16 2026-09-16 PrS Proposed sale
3.3
KIIL HARRY SKIP

Officer

Officer
36,983
63.91
US$2,836,423 		36,983 63.91 US$2,836,423
2026-07-09 2026-07-08 S Sale
Walter Matthew R.

SVP, Chief HR Officer

Officer
82,114 -34.5%
408.37
US$2,734,773 		82,114 -34.5% 408.37 US$2,734,773
2026-07-08 2026-07-08 PrS Proposed sale
Walter Matthew R.

Officer

Officer
3,102
83.15
US$257,931 		3,102 83.15 US$257,931
2026-06-09 2026-06-08 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
228 -0.6%
80.45
US$18,343 		228 -0.6% 80.45 US$18,343
2026-06-09 2026-06-08 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
3,961 -9.6%
80.44
US$318,623 		3,961 -9.6% 80.44 US$318,623
2026-06-08 2026-06-08 PrS Proposed sale
3.3
KIIL HARRY SKIP

Officer

Officer
4,189
80.44
US$336,965 		4,189 80.44 US$336,965
2026-02-26 2026-02-19 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
385 -1.2%
97.82
US$37,661 		385 -1.2% 97.82 US$37,661
2026-02-26 2026-02-19 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
668 -2.0%
97.83
US$65,347 		668 -2.0% 97.83 US$65,347
2026-02-26 2026-02-19 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
19,255 -36.3%
97.77
US$1,882,561 		19,255 -36.3% 97.77 US$1,882,561
2026-02-26 2026-02-19 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
30,568 -36.5%
97.66
US$2,985,375 		30,568 -36.5% 97.66 US$2,985,375
2026-02-26 2026-02-19 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
1,648 -1.9%
97.86
US$161,273 		1,648 -1.9% 97.86 US$161,273
2026-02-19 2026-02-19 PrS Proposed sale
3.3
KIIL HARRY SKIP

Officer

Officer
52,524
97.71
US$5,132,217 		52,524 97.71 US$5,132,217
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
500 -1.1%
102.08
US$51,040 		500 -1.1% 102.08 US$51,040
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
325 -0.7%
102.06
US$33,170 		325 -0.7% 102.06 US$33,170
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
227 -0.5%
102.05
US$23,165 		227 -0.5% 102.05 US$23,165
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
825 -1.7%
102.04
US$84,183 		825 -1.7% 102.04 US$84,183
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
1,995 -4.0%
102.03
US$203,550 		1,995 -4.0% 102.03 US$203,550
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
1,942 -3.7%
101.99
US$198,065 		1,942 -3.7% 101.99 US$198,065
2025-11-21 2025-11-19 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
24,186 -31.8%
101.93
US$2,465,279 		24,186 -31.8% 101.93 US$2,465,279
2025-11-19 2025-11-19 PrS Proposed sale
3.4
Smith Gregory L

Officer

Officer
30,000
101.95
US$3,058,452 		30,000 101.95 US$3,058,452
2025-09-05 2025-09-03 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
200 -0.6%
91.59
US$18,318 		200 -0.6% 91.59 US$18,318
2025-09-05 2025-09-03 S Sale
3.3
KIIL HARRY SKIP

EVP & President Cardiovascular

Officer
8,405 -19.0%
91.58
US$769,730 		8,405 -19.0% 91.58 US$769,730
2025-09-03 2025-09-03 PrS Proposed sale
3.3
KIIL HARRY SKIP

Officer

Officer
8,605
91.58
US$788,049 		8,605 91.58 US$788,049
2025-08-25 2025-08-25 B Purchase
2.4
Jellison William R
Non-Executive Director
2,500 +100.0%
92.37
US$230,925 		2,500 +100.0% 92.37 US$230,925
2025-08-25 2025-08-22 B Purchase
2.4
Jellison William R
Non-Executive Director
2,500 +inf%
92.73
US$231,825 		2,500 +inf% 92.73 US$231,825
2025-06-06 2025-06-06 PrS Proposed sale
3.2
Salmon Sean

Officer

Officer
18,378
86.81
US$1,595,469 		18,378 86.81 US$1,595,469
2025-01-27 2025-01-24 S Sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
12,437 -23.3%
90.00
US$1,119,330 		12,437 -23.3% 90.00 US$1,119,330
2025-01-24 2025-01-24 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
12,437
90.00
US$1,119,330 		12,437 90.00 US$1,119,330
2025-01-10 2025-01-08 S Sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
3,000 -6.9%
80.41
US$241,230 		3,000 -6.9% 80.41 US$241,230
2025-01-10 2025-01-08 S Sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
6,850 -13.5%
80.41
US$550,808 		6,850 -13.5% 80.41 US$550,808
2025-01-08 2025-01-08 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
9,850
80.41
US$792,038 		9,850 80.41 US$792,038
2024-10-31 2024-10-31 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Director

Non-Executive Director
30,000
89.73
US$2,691,794 		30,000 89.73 US$2,691,794
2024-10-30 2024-10-30 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Director

Non-Executive Director
15,000
90.58
US$1,358,740 		15,000 90.58 US$1,358,740
2024-10-29 2024-10-29 PrS Proposed sale
2.9
PARKHILL KAREN L

Former BOD
15,000
91.16
US$1,367,348 		15,000 91.16 US$1,367,348
2024-10-24 2024-10-24 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Director

Non-Executive Director
22,712
92.49
US$2,100,633 		22,712 92.49 US$2,100,633
2024-10-23 2024-10-23 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Director

Non-Executive Director
23,848
91.76
US$2,188,205 		23,848 91.76 US$2,188,205
2024-10-18 2024-10-18 PrS Proposed sale
2.9
PARKHILL KAREN L

Former BOD
48,825
91.74
US$4,479,310 		48,825 91.74 US$4,479,310
2024-10-17 2024-10-17 PrS Proposed sale
2.9
PARKHILL KAREN L

Former BOD
55,179
89.87
US$4,958,718 		55,179 89.87 US$4,958,718
2024-08-26 2024-08-26 PrS Proposed sale
2.9
PARKHILL KAREN L

Former Officer

Officer
2,668
90.00
US$240,120 		2,668 90.00 US$240,120
2024-06-11 2024-06-07 S Sale
1.9
Martha Geoffrey

Chairman and CEO

Executive Director
1,594 -1.1%
83.82
US$133,609 		1,594 -1.1% 83.82 US$133,609
2024-06-11 2024-06-07 S Sale
1.9
Martha Geoffrey

Chairman and CEO

Executive Director
17,519 -10.8%
83.76
US$1,467,391 		17,519 -10.8% 83.76 US$1,467,391
2024-06-07 2024-06-07 PrS Proposed sale
1.9
Martha Geoffrey

Officer; Director

Executive Director
19,113
83.77
US$1,601,102 		19,113 83.77 US$1,601,102
2024-04-09 2024-04-08 S Sale
2.7
Marinaro Michael

EVP & President, Surgical OU

Officer
854 -3.0%
83.14
US$71,002 		854 -3.0% 83.14 US$71,002
2024-02-23 2024-02-21 S Sale
3.2
Salmon Sean

EVP & President Cardiovascular

Officer
16,035 -24.9%
85.12
US$1,364,899 		16,035 -24.9% 85.12 US$1,364,899
2024-02-23 2024-02-21 S Sale
3.2
Salmon Sean

EVP & President Cardiovascular

Officer
13,066 -16.9%
85.15
US$1,112,570 		13,066 -16.9% 85.15 US$1,112,570
2024-02-23 2024-02-21 S Sale
3.2
Salmon Sean

EVP & President Cardiovascular

Officer
1,594 -2.0%
85.06
US$135,586 		1,594 -2.0% 85.06 US$135,586
2024-02-21 2024-02-21 PrS Proposed sale
3.2
Salmon Sean

Officer

Officer
30,695
85.13
US$2,613,202 		30,695 85.13 US$2,613,202
2023-12-20 2023-12-19 PlS Planned sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
4,997 -14.7%
82.17
US$410,603 		4,997 -14.7% 82.17 US$410,603
2023-12-19 2023-12-19 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
4,997
82.17
US$410,603 		4,997 82.17 US$410,603
2023-08-25 2023-08-23 S Sale
3.4
Smith Gregory L

EVP Global Ops & Supply Chain

Officer
10,000 -17.6%
83.84
US$838,400 		10,000 -17.6% 83.84 US$838,400
2023-08-23 2023-08-23 PrS Proposed sale
3.4
Smith Gregory L

Officer

Officer
10,000
83.84
US$838,442 		10,000 83.84 US$838,442
2023-08-16 2023-08-14 PlS Planned sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
1,000 -2.9%
83.38
US$83,380 		1,000 -2.9% 83.38 US$83,380
2023-08-14 2023-08-14 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
1,000
83.38
US$83,380 		1,000 83.38 US$83,380
2023-08-07 2023-08-04 PlS Planned sale
2.7
Marinaro Michael

EVP & President, Surgical OU

Officer
1,352 -4.5%
84.11
US$113,717 		1,352 -4.5% 84.11 US$113,717
2023-08-04 2023-08-04 PrS Proposed sale
2.7
Marinaro Michael

Officer

Officer
1,352
84.11
US$113,717 		1,352 84.11 US$113,717
2023-07-18 2023-07-14 PlS Planned sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
2,000 -7.7%
87.97
US$175,940 		2,000 -7.7% 87.97 US$175,940
2023-07-14 2023-07-14 PrS Proposed sale
2.0
Wall Brett A.

Officer

Officer
2,000
87.97
US$175,940 		2,000 87.97 US$175,940
2023-07-12 2023-07-10 S Sale
2.3
TEN HOEDT ROB

EVP and Pres. Global Regions

Officer
3,706 -7.8%
86.58
US$320,865 		3,706 -7.8% 86.58 US$320,865
2023-07-12 2023-07-10 S Sale
2.3
TEN HOEDT ROB

EVP and Pres. Global Regions

Officer
1,808 -4.0%
86.59
US$156,555 		1,808 -4.0% 86.59 US$156,555
2023-07-10 2023-07-10 PrS Proposed sale
2.3
TEN HOEDT ROB

Officer

Officer
5,514
86.59
US$477,440 		5,514 86.59 US$477,440
2022-12-16 2022-12-13 S Sale
3.2
Salmon Sean

EVP & President Cardiovascular

Officer
16,631 -31.5%
80.50
US$1,338,736 		16,631 -31.5% 80.50 US$1,338,736
2022-10-17 2022-10-14 S Sale
2.3
TEN HOEDT ROB

EVP and Pres. Global Regions

Officer
2,404 -5.2%
81.54
US$196,015 		2,404 -5.2% 81.54 US$196,015
2022-03-21 2022-03-18 PlS Planned sale
2.9
PARKHILL KAREN L

EVP & Chief Financial Officer

Officer
682 -1.9%
110.00
US$75,020 		682 -1.9% 110.00 US$75,020
2022-03-14 2022-03-11 S Sale
2.5
Surface Carol A

SVP, Chief HR Officer

Officer
6,000 -17.4%
105.30
US$631,800 		6,000 -17.4% 105.30 US$631,800
2021-12-17 2021-12-16 B Purchase
3.7
ANDERSON RICHARD H
Non-Executive Director
5,010 +4.8%
103.26
US$517,333 		5,010 +4.8% 103.26 US$517,333
2021-12-07 2021-12-06 PlS Planned sale
2.9
PARKHILL KAREN L

EVP & Chief Financial Officer

Officer
682 -1.9%
110.00
US$75,020 		682 -1.9% 110.00 US$75,020
2021-10-01 2021-09-30 PlS Planned sale
1.2
Lerman Bradley E

SVP General Counsel & Corp Sec

Officer
49,147 -50.2%
126.58
US$6,221,027 		49,147 -50.2% 126.58 US$6,221,027
2021-08-26 2021-08-25 S Sale
3.2
Salmon Sean

EVP & Pres Diabetes/Cardiovasc

Officer
7,290 -17.9%
134.09
US$977,516 		7,290 -17.9% 134.09 US$977,516
2021-08-26 2021-08-25 S Sale
3.2
Salmon Sean

EVP & Pres Diabetes/Cardiovasc

Officer
21,129 -38.8%
134.08
US$2,832,976 		21,129 -38.8% 134.08 US$2,832,976
2021-08-04 2021-08-02 PlS Planned sale
1.2
Lerman Bradley E

SVP General Counsel & Corp Sec

Officer
4,000 -7.7%
131.52
US$526,080 		4,000 -7.7% 131.52 US$526,080
2021-06-17 2021-06-15 PlS Planned sale
2.9
PARKHILL KAREN L

EVP & Chief Financial Officer

Officer
605 -0.7%
124.47
US$75,304 		605 -0.7% 124.47 US$75,304
2021-06-02 2021-06-01 PlS Planned sale
2.0
Wall Brett A.

EVP & Pres Neuroscience

Officer
2,473 -10.3%
128.07
US$316,717 		2,473 -10.3% 128.07 US$316,717
2021-06-01 2021-05-28 PlS Planned sale
Liddicoat John R

EVP & President of Americas

Officer
34,656 -44.9%
126.65
US$4,389,182 		34,656 -44.9% 126.65 US$4,389,182
2021-04-07 2021-04-05 PlS Planned sale
1.9
Martha Geoffrey

CEO

Executive Director
9,308 -10.2%
118.83
US$1,106,070 		9,308 -10.2% 118.83 US$1,106,070
Explore more

More insider trading research around Medtronic PLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America